EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Artemisia absinthium (wormwood)–induced toxic hepatitis: First reported cases with contrasting clinical outcomes

Muhammed Furkan Keser, Yahya Atayan, Murat Harputluoglu, Yuksel Seckin, Mehmet Ali Erdogan, Mustafa Duru

Hepatology Forum · 2026 · 7 (4) · 424-427

DOI: 10.14744/hf.2025.88951 ↗
AbstractBibliografische Angaben

Abstract

Artemisia absinthium (wormwood) is a widely used herbal product believed to possess hepatoprotective and anti-inflammatory properties; however, its volatile component, thujone, may cause hepatotoxicity under certain conditions. Reports of A. absinthium–induced liver injury in humans are extremely rare. We describe two cases of toxic hepatitis following A. absinthium use with contrasting clinical outcomes. The first patient, a 24-year-old woman, consumed 5 g daily for six consecutive days to enhance lactation and recovered completely with supportive treatment. The second patient, a 52-year-old man, used approximately 10 g twice daily for one week to relieve urinary complaints, developed acute liver failure, underwent liver transplantation, and subsequently died. To our knowledge, these are the first documented human cases of A. absinthium–associated hepatotoxicity. These cases highlight the potential hepatotoxic risk of uncontrolled herbal use and emphasize the need for further studies to define its hepatotoxic potential.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →